Value-based drug pricing makes sense, but is difficult to pull off | DrugPatentWatch
It’s hard not to like the notion of value-based pricing for prescription drugs. It aims to ensure that the prices we pay for drugs reflect the benefits they provide, either in terms of longer life or better quality of life. And what could be more American than letting the market determine the right price through the intersection […]
Connect
Follow via RSS feed or on the following social media platforms.